ANDOVER, Mass., Nov. 19 (HSMN NewsFeed) -- Smith & Nephew's (NYSE: SNN ; LSE: SN ) Endoscopy Division today announced the sale of its vascular business to InaVein LLC, a Boston-area investor group led by Jonathan Donaldson and Patrick Maley, longstanding members of the medical device marketplace. Terms of the sale were not disclosed.
The sale supports Endoscopy's objective to refine its product portfolio as part of Smith & Nephew's overall Earnings Improvement Program, which was announced early this year.The vascular business includes The TRIVEX(TM) System for minimally invasive removal of varicose veins, and the Tumescent Catheter Inversion (TCI) System for the removal of the greater saphenous vein, a procedure which can prevent further varicose vein formation.
Full text >>
Monday, November 19, 2007
Smith & Nephew Endoscopy Announces the Sale of its Vascular Business
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment